Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8


Modeling Corticosteroid Pharmacogenomics and Proteomics in Rat Liver.

Ayyar VS, Sukumaran S, DuBois DC, Almon RR, Jusko WJ.

J Pharmacol Exp Ther. 2018 Oct;367(1):168-183. doi: 10.1124/jpet.118.251959. Epub 2018 Aug 7.


Receptor/gene/protein-mediated signaling connects methylprednisolone exposure to metabolic and immune-related pharmacodynamic actions in liver.

Ayyar VS, Sukumaran S, DuBois DC, Almon RR, Qu J, Jusko WJ.

J Pharmacokinet Pharmacodyn. 2018 Aug;45(4):557-575. doi: 10.1007/s10928-018-9585-x. Epub 2018 Apr 27.


Mechanistic Multi-Tissue Modeling of Glucocorticoid-Induced Leucine Zipper Regulation: Integrating Circadian Gene Expression with Receptor-Mediated Corticosteroid Pharmacodynamics.

Ayyar VS, DuBois DC, Almon RR, Jusko WJ.

J Pharmacol Exp Ther. 2017 Oct;363(1):45-57. doi: 10.1124/jpet.117.242990. Epub 2017 Jul 20.


Functional proteomic analysis of corticosteroid pharmacodynamics in rat liver: Relationship to hepatic stress, signaling, energy regulation, and drug metabolism.

Ayyar VS, Almon RR, DuBois DC, Sukumaran S, Qu J, Jusko WJ.

J Proteomics. 2017 May 8;160:84-105. doi: 10.1016/j.jprot.2017.03.007. Epub 2017 Mar 14.


Quantitative tissue-specific dynamics of in vivo GILZ mRNA expression and regulation by endogenous and exogenous glucocorticoids.

Ayyar VS, Almon RR, Jusko WJ, DuBois DC.

Physiol Rep. 2015 Jun;3(6). pii: e12382. doi: 10.14814/phy2.12382.


Russell Silver syndrome: a perspective on growth and the influence of growth hormone therapy.

Mascarenhas JV, Ayyar VS.

Indian J Endocrinol Metab. 2012 Sep;16(5):840-2. doi: 10.4103/2230-8210.100675.


Type 2 DM is not coronary artery disease equivalent.

Ayyar VS.

Indian J Endocrinol Metab. 2012 May;16(3):472. doi: 10.4103/2230-8210.95718. No abstract available.


History of growth hormone therapy.

Ayyar VS.

Indian J Endocrinol Metab. 2011 Sep;15 Suppl 3:S162-5. doi: 10.4103/2230-8210.84852.

Supplemental Content

Loading ...
Support Center